Lymphoma-like syndrome following para-aminosalicylic acid.

Lymphoma-like syndrome following para-aminosalicylic acid.

This report describes a patient who developed a Hodgkin's disease-like picture both clinically and pathologically, following the administration of para-aminosalicylic acid, with complete regression on cessation of therapy.

Para-Aminosalicylic Acid: Pas

Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid.

Use of para-aminosalicylic acid in chronic pulmonary tuberculosis.

The Pharmacokinetics of Para-Aminosalicylic Acid in HIV-

19 The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) 20 Mycobacterium tuberculosis prompted the reintroduction of para-aminosalicylic acid 21 (PAS) to protect companion anti-tuberculosis drugs from additional acquired resistance. 22 In sub-Saharan Africa, MDR/XDR tuberculosis with HIV co-infection is common and 23 concurrent treatment of HIV-infection and MDR/XDR t...